Also trades as: SNBIF (OTC) · $vol 0M
4592.T JPX
SanBio Company Limited
1W: -1.1%
1M: -3.0%
3M: -5.7%
YTD: -52.2%
1Y: -64.5%
3Y: +57.1%
5Y: -34.2%
¥944.00 ($5.98)
+3.00 (+0.32%)
Weekly Expected Move ±6.5%
¥819
¥880
¥941
¥1002
¥1063
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$15.6B
+353.1% ▲
5Y CAGR: +3.2%
Total Liabilities
$2.0B
+19.7% ▲
5Y CAGR: -16.6%
Shareholders Equity
$13.6B
+671.7% ▲
5Y CAGR: +10.3%
Cash & Investments
$15.1B
+416.3% ▲
5Y CAGR: +3.9%
Total Debt
$1.2B
+212.0% ▲
5Y CAGR: -20.9%
Net Debt
-$13.8B
-448.4% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $4.6B | $6.7B | $4.5B | $2.9B | $15.1B |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $4.6B | $6.7B | $4.5B | $2.9B | $15.1B |
| Net Receivables | $0 | $0 | $0 | $0 | $0 |
| Inventory | $468M | $0 | $0 | $0 | $0 |
| Other Current Assets | $144M | $188M | $124M | $144M | $207M |
| Total Current Assets | $5.4B | $7.0B | $4.9B | $3.3B | $15.5B |
| Property, Plant & Equip. | $59M | $48M | $44M | $40M | $69M |
| Goodwill & Intangibles | $66M | $1M | $44M | $44M | $44M |
| Long-Term Investments | $34K | $28K | $21M | $0 | $0 |
| Other Non-Current Assets | $34M | $29M | $710K | $28M | $19M |
| Total Non-Current Assets | $159M | $78M | $110M | $112M | $132M |
| Total Assets | $5.5B | $7.0B | $5.0B | $3.4B | $15.6B |
| — Liabilities — | |||||
| Accounts Payable | $0 | $0 | $0 | $139M | $0 |
| Short-Term Debt | $512M | $268M | $268M | $268M | $129M |
| Deferred Revenue | $936M | $707M | $0 | $0 | $0 |
| Other Current Liabilities | -$130M | $54M | $611M | $315M | $392M |
| Total Current Liabilities | $1.5B | $1.1B | $906M | $732M | $534M |
| Long-Term Debt | $2.0B | $665M | $397M | $129M | $1.1B |
| Other Non-Current Liab. | $0 | $1K | $0 | $0 | $0 |
| Total Non-Current Liabilities | $2.0B | $1.5B | $1.3B | $952M | $1.5B |
| Total Liabilities | $3.5B | $2.6B | $2.3B | $1.7B | $2.0B |
| — Equity — | |||||
| Common Stock | $4.1B | $6.4B | $3.3B | $2.5B | $8.4B |
| Retained Earnings | -$9.1B | -$8.2B | -$2.0B | -$699M | -$996M |
| Accumulated OCI | -$768M | -$3.9B | -$5.6B | -$6.2B | -$5.9B |
| Total Stockholders Equity | $2.0B | $4.4B | $2.8B | $1.8B | $13.6B |
| Total Liabilities & Equity | $5.5B | $7.0B | $5.0B | $3.4B | $15.6B |
| — Key Metrics — | |||||
| Total Debt | $2.5B | $933M | $665M | $397M | $1.2B |
| Net Debt | -$2.0B | -$5.8B | -$3.8B | -$2.5B | -$13.8B |
| Total Investments | $34K | $28K | $21M | $0 | $0 |